Association of PCSK9 Variants With the Risk of Atherosclerotic Cardiovascular Disease and Variable Responses to PCSK9 Inhibitor Therapy

Chayakrit Krittanawong, Muzamil Khawaja, Robert S. Rosenson, Christopher I. Amos, Vijay Nambi, Carl J. Lavie, Salim S. Virani

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Association of PCSK9 Variants With the Risk of Atherosclerotic Cardiovascular Disease and Variable Responses to PCSK9 Inhibitor Therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences